Avistone Pharmaceuticals procures over $200m

Avistone Pharmaceuticals, a clinical-stage biotechnology company focused on precision oncology therapeutics, has raised over $200 million in funding.

Avistone Pharmaceuticals, a clinical-stage biotechnology company focused on precision oncology therapeutics, has raised over $200 million in funding. Vivo Capital led the round.

Source: Press Release